Georgia Public Health Lab

Axion BioSystems, based in Atlanta, GA, specializes in advanced live-cell assay technology, providing researchers with tools to understand human biology for disease research and therapeutic discovery. Their innovative products, such as the Maestro Volt and various automated cell counters, offer scientists unprecedented access to dynamic cellular behavior without invasive procedures. With a strong focus on applications in neuroscience, oncology, virology, and stem cell culture, Axion BioSystems is utilized by top pharmaceutical companies and maintains a customer satisfaction rating of 4.7 out of 5. The company aims to empower researchers by simplifying the complexities of cellular analysis, enabling faster and more precise scientific breakthroughs. Generated from the website

UCB Pharma is one of many wholly-owned subsidiaries of UCB S.A., a biopharmaceutical leader specializing in fields of central nervous system disorders, allergy and respiratory diseases, immune and inflammatory disorders and oncology. The company s main products include Keppra, Xyzal, Nootropil, Atarax, Lortab, Tussionex, Metadate CD, Equasym XL and Dipentum. The company directs profits from the sale and distribution of its products toward further research in its many fields. UCB Pharma s parent company maintains numerous additional facilities worldwide. The company recently acquired Celltech Group, helping form one of the world s largest biopharmaceutical companies. UCB was founded in 1928 by Emmanuel Janssen, a far-sighted Belgian businessman. UCB Pharma maintains its headquarters in Smyrna, Ga.

Mygenomics LLC, based in Alpharetta, GA, is a specialized next-generation sequencing (NGS) service provider that offers a range of genetic testing solutions, including RT-PCR tests, hereditary genetic disease risk assessments, and ancestry and lifestyle testing. With a highly experienced team of PhD scientists and a commitment to high-quality genetic services, they adhere to strict guidelines from recognized authorities such as the American College of Medical Genetics and the Clinical Laboratory Improvement Amendments. Dedicated to delivering rapid and accurate testing services, Mygenomics is particularly noted for its efficient COVID-19 testing, featuring turnaround times as swift as three hours. Their offerings encompass various genetic panels for cancer genomics and infectious disease testing, positioning them as a trusted resource for both medical professionals and patients seeking insights into their genetic health. Generated from the website